Selective inhibition of nicotinamide adenine dinucleotide dependent oxidation by 2-methyl-3-o-tolyl-4-quinazolone.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism*; D002951:Citrates / Q000378:metabolism*; D002952:Citric Acid Cycle; D004579:Electron Transport; D005971:Glutamates / Q000378:metabolism*; D006885:Hydroxybutyrates / Q000378:metabolism*; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D066298:In Vitro Techniques; D007656:Ketoglutaric Acids / Q000378:metabolism*; D008293:Malates / Q000378:metabolism*; D008702:Methaqualone / Q000187:drug effects; D008928:Mitochondria / Q000378:metabolism*; D009243:NAD / Q000302:isolation & purification*; D051381:Rats / Q000494:pharmacology; D013347:Subcellular Fractions / Q000378:metabolism; D013385:Succinate Dehydrogenase / Q000378:metabolism
D000927:Anticonvulsants; D002951:Citrates; D005971:Glutamates; D006885:Hydroxybutyrates; D006993:Hypnotics and Sedatives; D007656:Ketoglutaric Acids; D008293:Malates; D009243:NAD; D008702:Methaqualone; D013385:Succinate Dehydrogenase